Jonathan Bluth is a Managing Director within the firm’s Healthcare Provider Services and Healthcare Outsourced Services industry teams, advising healthcare services companies, physician groups, behavioral healthcare providers, revenue cycle management companies, diagnostics providers, and private equity investors on M&A transactions, capital raises, and strategic alternatives. Jonathan’s more than 25 years of experience in healthcare consulting, corporate finance, and healthcare investment banking helps him advise healthcare services clients on transaction strategy, valuation considerations, buyer positioning, and buy- and sell-side M&A.
Jonathan is a frequent speaker on healthcare M&A at industry conferences such as Home Care 100, the Autism Investor Summit, and Becker’s annual RCM Conference and has been recognized by the LA Business Journal as a “Trusted Healthcare Advisor” and an “Influential Investment Banker.” Jonathan is frequently quoted as a thought leader in Behavioral Health Business, Axios, Levin Associates, and The Deal, among other leading finance and trade publications.
Prior to joining BGL, Jonathan was the co-head of healthcare at Intrepid Investment Bankers LLC and held investment banking positions at Deloitte Corporate Finance LLC and Cowen and Company. Jonathan was a member of the revenue cycle consulting practices at Cap Gemini Ernst & Young and Navigant, where he was a subject matter specialist in patient access redesign and process improvement. He also held senior corporate finance positions with Vantage Oncology, Inc. and Alliance HealthCare Services.
As payer scrutiny of autism therapy claims grows, providers need a revenue cycle that holds up under audit. Executives and investors discuss how denial root-cause insights, national benchmarking, and automation protect cash flow and clinical credibility.
